Mixing of Covaxin and Covishield to be carried out

A study regarding the mixing of two vaccines, Covaxin and Covishield is been given a heads up. These are the two main vaccines used in India right now. The DCGI has approved the mixing of these two vaccines.

The clinical trails of the vaccines will take place in Vellore, at Vellore&rsqu...

PETER SCHIFF: GRAYSCALE WILL SELL BTC TO FUND BUYBACK OF GBTC

Highlights:

•          Peter Schiff does not think bitcoin is of any value

•          The statements about Grayscale selling its BTC has been refuted by the company  <...

BHARAT BIOTECH GETS DCGI APPROVAL TO CONDUCT COVAXIN TEST THROUGH SKIN

Highlights

• According to the reports, the approval from the DCGI is subject to two conditions

• It is stated that if these clinical trials are successful, the vaccine will be available at a cheaper cost

• Union Minister Dr Harsh Vardhan said if everyt...

COVID-19 VACCINE: DCGI APPROVES PHASE 2 AND 3 CLINICAL TRIALS OF OXFORD VACCINE BY SERUM INSTITUTE

Highlights

• DCGI Dr V G Somani granted approval for conducting phase 2 and 3 human clinical trials by the SII

• ‘Covishield’ a potential vaccine for COVID-19 has been developed by the University of Oxford

• Before starting the phase 3 tria...

FURTHER SIX MONTHS FOR SAFE COVID-19 VACCINE SAYS SERUM INSTITUTE OF INDIA

Serum Institute of India (SII), Indian vaccine developer from the city of Pune has stated that it will take at least six months before we see arrival of COVID-19 vaccine that will be safe to use for general public. The need for the vaccine seems extremely urgent as the number of COVID-19 cases in...

COVAXIN: INDIA’S FIRST COVID-19 VACCINE TO BE TESTED ON 375 PEOPLE IN PHASE I

COVAXIN, the first indigenous COVID-19 vaccine from India is all set to start its human trials from next week. Bharat Biotech, a Hyderabad-based company in association with ICMR and NIV, Pune developed a COVID-19 vaccine that got approval from the DCGI to conduct human trials in the last week. As...

ZYDUS CADILA RECEIVE DCGI NOD FOR HUMAN CLINICAL TRIALS FOR COVID-19 VACCINE

Highlights

• Ahmedabad-based Zydus Cadila Healthcare Ltd will complete the Phase I and Phase II Human clinical trials in three months

• According to the data submitted to the DCGI, the vaccine candidate was found successful in terms of safety and immunogenicity

ICMR-BHARAT BIOTECH TO LAUNCH ‘COVAXIN’ BY AUGUST 15

The people of India are hopeful since a company named Bharat Biotech International Limited (BBIL) from Hyderabad is association with the Indian Council of Medical Research (ICMR) got approval from the Drug Controller General of India (DCGI) to conduct Phase I, II Human clinical trials for the COV...

INDIAN GOVERNMENT APPROVES REMDESIVIR, SOON TO START DOMESTIC PRODUCTION

Highlights

• The Drug Controller General of India (DCGI) has approved use of the anti-viral drug Remdesivir 

• Remdesivir is permitted for ‘restricted emergency use' on severely ill coronavirus patients

• At present, India’s top fo...